4.7 Review

Bioengineering Technologies for Cardiac Regenerative Medicine

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2021.681705

关键词

bioengineering; cardiac repair; cell reprogramming; exosome; cardiac patch; targeting

资金

  1. National Institutes of Health [R01 HL123920, HL137093, HL144002, HL146153, HL147357]
  2. American Heart Association [18TPA34230092, 19EIA34660286]

向作者/读者索取更多资源

The combination of bioengineering and cardiac regenerative medicine provides innovative solutions to challenges such as lack of adult cardiac stem cells and difficulty in therapeutic delivery to the injured heart. Advanced technologies like cell reprogramming, gene editing, and protein factors are being utilized to overcome limitations and improve outcomes in cardiac regenerative medicine.
Cardiac regenerative medicine faces big challenges such as a lack of adult cardiac stem cells, low turnover of mature cardiomyocytes, and difficulty in therapeutic delivery to the injured heart. The interaction of bioengineering and cardiac regenerative medicine offers innovative solutions to this field. For example, cell reprogramming technology has been applied by both direct and indirect routes to generate patient-specific cardiomyocytes. Various viral and non-viral vectors have been utilized for gene editing to intervene gene expression patterns during the cardiac remodeling process. Cell-derived protein factors, exosomes, and miRNAs have been isolated and delivered through engineered particles to overcome many innate limitations of live cell therapy. Protein decoration, antibody modification, and platelet membranes have been used for targeting and precision medicine. Cardiac patches have been used for transferring therapeutics with better retention and integration. Other technologies such as 3D printing and 3D culture have been used to create replaceable cardiac tissue. In this review, we discuss recent advancements in bioengineering and biotechnologies for cardiac regenerative medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据